• IR-1061 for Deep-Tissue NIR Imaging Workflows

  2026-09-26

  IR-1061 is a near infrared fluorescent dye for OTN-NIR research, but its performance depends on how it is formulated—not simply on the amount of dye added. This workflow-focused guide translates polymer-encapsulation findings into practical loading, control, and troubleshooting choices for deep-tissue imaging studies.

• Pemetrexed in Mesothelioma: Reading DNA Repair Context

  2026-09-25

  Pemetrexed is more than a cytotoxic benchmark: its effects can be interpreted alongside tumor DNA-repair state. This article explains how to separate antifolate response from homologous-recombination vulnerability when designing malignant mesothelioma research.

• Chloroquine: From Lysosomal Mechanism to Translation

  2026-09-25

  Chloroquine is a powerful research probe—but its lysosomal effects, broad immune activity, and uneven translation across models demand careful experimental interpretation.

• Tetrahydromagnolol in CB2 Signaling Workflows

  2026-09-24

  Use Tetrahydromagnolol to probe CB2-linked signaling and test carefully framed hypotheses about inflammation or cell motility. Its reported CB2 potency and GPR55 antagonism support dose-aware workflows—but do not establish a role in the TBXA2R–ERM pathway.

• ABT-263 (Navitoclax): Mechanism and Research Use

  2026-09-24

  ABT-263 (Navitoclax) inhibits anti-apoptotic Bcl-2 family proteins and is used to investigate mitochondrial apoptosis in cancer models. Its value in an apoptosis assay depends on the model’s apoptotic priming and survival-protein profile, so results should not be inferred from target expression alone.

• ARCA Cy5 EGFP mRNA (5-moUTP): Assay Guide

  2026-09-23

  Track labeled mRNA and its translated EGFP product in the same experiment to distinguish delivery from expression. This practical guide shows how to use the reporter to optimize cell-based delivery assays—and where conclusions should stop before moving to disease models.

• Laminin (925-933): A Mechanism-First Assay Guide

  2026-09-23

  Laminin (925-933) is a defined Laminin B1 chain peptide for dissecting receptor-dependent adhesion and chemotaxis. This guide connects its ECM biology with lessons from tau research to improve assay controls, interpretation, and translational relevance.

• Disulfiram Workflows for Proteasome and Pyroptosis

  2026-09-22

  Disulfiram supports two complementary research workflows: copper-associated proteasome inhibition in cancer models and covalent modulation of GSDMD-linked pyroptosis. This guide translates those mechanisms into practical assay design, dosing, controls, and troubleshooting strategies.

• IR-1061: From Dye to Deep-Imaging Strategy

  2026-09-22

  IR-1061 is more than a bright NIR fluorophore: its performance depends on molecular state, hydrophobic confinement, polymer affinity, and formulation stability. This thought-leadership guide translates mechanistic evidence into practical strategy for researchers developing OTN-NIR imaging systems.

• Cefodizime Workflows for Infection Research

  2026-09-21

  Cefodizime combines broad antibacterial coverage with a practical research profile for MIC testing, time-kill studies, resistance surveillance, and host-response experiments. This guide translates its PBP-targeting mechanism and reported immunomodulatory effects into reproducible workflows while highlighting solvent, strain-selection, and interpretation controls.

• Borneol Sensitizes TNBC to Gemcitabine via PTGS2

  2026-09-21

  The 2026 reference study identifies PTGS2 as a direct molecular target through which borneol intensifies gemcitabine-induced DNA damage in triple-negative breast cancer models. Its combined cell, animal, target-engagement, and rescue experiments support a PTGS2–ATM/ATR-CHK1/CHK2 mechanism, while also indicating that clinical translation requires further pharmacological and patient-level validation.

• Pemetrexed: A DNA-Repair-Aware Assay Strategy

  2026-09-20

  Pemetrexed is more than a broad antifolate cytotoxicity probe. This guide develops a DNA-repair-aware assay strategy that connects folate-pathway inhibition with malignant mesothelioma biology, enabling more informative interpretation of combination, resistance, and biomarker experiments.

• Miltefosine Activates Ras/MEK/ERK in Leukopenia

  2026-09-19

  The reference study identifies Miltefosine as a potential leukopenia treatment that promotes neutrophil differentiation through Ras/MEK/ERK signaling. By combining cell-based assays, an irradiation-induced mouse model, transcriptomics, network pharmacology, docking, and pathway inhibition, the authors connect restored myelopoiesis with ERK-dependent signaling.

• Biotin-HPDP: Reliable Thiol Labeling

  2026-09-18

  Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide), SKU A8008, supports reversible thiol-specific protein labeling alongside cell viability, proliferation, and cytotoxicity assays. This scenario-based guide explains compatibility, optimization, interpretation, and practical vendor-selection criteria for reproducible biochemical workflows.

• D-Luciferin Potassium Salt for Translational BLI

  2026-09-18

  Build reproducible luciferase workflows for tumor cell tracking, reporter assays, and postoperative glioblastoma studies with D-Luciferin potassium salt. This guide connects practical substrate handling with the biomaterial and therapeutic insights of a recent brain-tumor hydrogel study.

8059 records 1/538 page Next 12345 下5页 Last page